Understanding the functional role of kappa opioid receptor signaling in somatosensory neurons
了解卡帕阿片受体信号传导在体感神经元中的功能作用
基本信息
- 批准号:9258162
- 负责人:
- 金额:$ 4.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-12-01 至 2018-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdverse effectsAfferent NeuronsAgonistAmericanAnatomyBehavioralBehavioral AssayBiological AssayC FiberCalciumCellsClinical TreatmentClinical TrialsDataDorsalDrug TargetingDynorphinsElectrophysiology (science)Free Nerve EndingHumanInflammatoryKnock-in MouseKnowledgeMeasuresMediatingModalityMolecularMusNeuraxisNeuronsOpioidOrganPainPain managementPathologicPathway interactionsPeripheralPharmaceutical PreparationsPhysiologic pulsePhysiologicalPropertyPruritusQuality of lifeReceptor SignalingRegulationResearch TrainingRoleSeizuresSensorySkinSpinal CordStimulusSystemTestingTherapeuticTimeTreatment EfficacyWorkalternative treatmentbasebehavior testbehavioral responsecellular targetingchronic itchchronic paindelta opioid receptordorsal horneffective therapyexperimental studyinflammatory paininsightkappa opioid receptorsmedical attentionneurochemistryneurotransmitter releaseoptogeneticspain behaviorpatch clamppresynapticreceptorresponsesomatosensorytherapeutic targetvoltage
项目摘要
Chronic itch and pain are debilitating conditions that significantly decrease quality of life of millions worldwide and are primary reasons that Americans seek medical attention. Nevertheless, few treatments exist that effectively reduce itch or pain without causing severe adverse effects. This is, in part, because current therapies act on central targets whose mechanisms are poorly understood. Therefore, increasing our knowledge of the regulation of physiologic itch and pain is critical for developing safer and more effective therapies. This proposal aims to reduce this gap, thereby providing insight into the peripheral modulation of itch and pain. Our lab has previously shown that the kappa opioid dynorphin inhibits itch within the dorsal spinal cord. This effect may have been due, at least in part, to presynaptic inhibition via the action of dynorphin on primary sensory afferents in the spinal cord. I now have preliminary data indicating that peripherally selective kappa opioids may inhibit inflammatory itch and pain and reduce thermal sensitivity, suggesting a modulatory role for KOR in conveying these sensory modalities in primary afferent neurons. Therefore, I hypothesize that peripherally selective agonists will act through KOR to inhibit inflammatory itch and pain and reduce thermal sensitivity. This proposal will investigate the functional role of KOR signaling in somatosensory neurons through anatomical, electrophysiological, and behavioral approaches. I will characterize KOR-Cre+ DRG neurons to determine the molecular identity and visualize their peripheral and central projections (Aim 1); use patch-clamp electrophysiology and optogenetic strategies to analyze whether primary afferents express functional levels of KOR and whether these effects occur on peripheral terminals, central terminals, or both (Aim 2); and measure alterations in the behavioral responses to itch and pain-induced stimuli in the presence or absence of peripherally selective kappa opioids (Aim 3). These experiments will elucidate the function of KOR signaling on somatosensory neurons with the potential to identify safer, more effective therapeutic targets for chronic itch and pain.
慢性瘙痒和疼痛是一种使人衰弱的疾病,会显着降低全世界数百万人的生活质量,也是美国人寻求医疗救助的主要原因。然而,很少有治疗方法可以有效减轻瘙痒或疼痛而不引起严重的副作用。部分原因是目前的疗法作用于中心靶点,但其机制尚不清楚。因此,增加我们对生理性瘙痒和疼痛调节的了解对于开发更安全、更有效的疗法至关重要。该提案旨在缩小这一差距,从而深入了解瘙痒和疼痛的外周调节。我们的实验室此前已证明卡帕阿片类强啡肽可抑制背脊髓内的瘙痒。这种效应可能至少部分是由于强啡肽对脊髓初级感觉传入的作用而产生的突触前抑制。我现在有初步数据表明外周选择性卡帕阿片类药物可能抑制炎症瘙痒和疼痛并降低热敏感性,这表明 KOR 在初级传入神经元中传递这些感觉模式方面具有调节作用。因此,我推测外周选择性激动剂将通过 KOR 发挥作用,抑制炎症瘙痒和疼痛并降低热敏感性。该提案将通过解剖学、电生理学和行为学方法研究 KOR 信号在体感神经元中的功能作用。我将表征 KOR-Cre+ DRG 神经元以确定分子身份并可视化它们的外周和中心投影(目标 1);使用膜片钳电生理学和光遗传学策略来分析初级传入神经是否表达 KOR 的功能水平以及这些影响是否发生在外周末梢、中枢末梢或两者上(目标 2);并测量在存在或不存在外周选择性卡帕阿片类药物的情况下对瘙痒和疼痛引起的刺激的行为反应的变化(目标 3)。这些实验将阐明 KOR 信号在体感神经元上的功能,并有可能确定更安全、更有效的慢性瘙痒和疼痛治疗靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Chi-Chung Chiang其他文献
Michael Chi-Chung Chiang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
儿童药品不良反应主动监测中时序处理策略的方法学研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于真实世界医疗大数据的中西药联用严重不良反应监测与评价关键方法研究
- 批准号:82274368
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于隐狄利克雷分配模型的心血管系统药物不良反应主动监测研究
- 批准号:82273739
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于真实世界数据的创新药品上市后严重罕见不良反应评价关键方法研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
OR10G7错义突变激活NLRP3炎症小体致伊马替尼严重皮肤不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Perception of Dead Conspecifics modulates neural signaling and lifespan in Caenorhabditis elegans
对死亡同种的感知调节秀丽隐杆线虫的神经信号和寿命
- 批准号:
10828478 - 财政年份:2023
- 资助金额:
$ 4.9万 - 项目类别:
Impact of Early Life Experience on Vagal Neurons and Circuits
早期生活经历对迷走神经元和回路的影响
- 批准号:
10461651 - 财政年份:2021
- 资助金额:
$ 4.9万 - 项目类别: